IDEXX LABORATORIES INC /DE Goodwill
IDEXX LABORATORIES INC /DE (IDXX) had Goodwill of $410.95 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:Goodwill · last filed 2026-08-04
- 2026-06-30: Goodwill $410.95M.
- 2026-03-31: Goodwill $412.10M.
- 2025-12-31: Goodwill $414.00M.
- 2025-09-30: Goodwill $413.65M.
| Period end | Goodwill | Goodwill as first filed |
|---|---|---|
| 2026-06-30 | $410.95M 10-Q · filed 2026-08-04 | |
| 2026-03-31 | $412.10M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $414.00M 10-Q · filed 2026-08-04 | |
| 2025-09-30 | $413.65M 10-Q · filed 2025-11-03 | |
| 2025-06-30 | $414.49M 10-Q · filed 2025-08-04 | |
| 2025-03-31 | $407.49M 10-Q · filed 2025-05-01 | |
| 2024-12-31 | $405.10M 10-K · filed 2026-02-20 | |
| 2024-09-30 | $412.07M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $408.02M 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $408.67M 10-Q · filed 2024-05-01 | |
| 2023-12-31 | $366.00M 10-K · filed 2026-02-20 | $365.96M 10-K · filed 2024-02-22 |
| 2023-09-30 | $361.77M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $364.21M 10-Q · filed 2023-08-01 | |
| 2023-03-31 | $362.94M 10-Q · filed 2023-05-02 | |
| 2022-12-31 | $361.80M 10-K · filed 2025-02-21 | |
| 2022-09-30 | $355.29M 10-Q · filed 2022-11-01 | |
| 2022-06-30 | $355.53M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $360.97M 10-Q · filed 2022-05-04 | |
| 2021-12-31 | $359.35M 10-K · filed 2025-02-21 | |
| 2021-09-30 | $355.24M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $353.84M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $242.59M 10-Q · filed 2021-05-04 | |
| 2020-12-31 | $243.35M 10-K · filed 2024-02-22 | |
| 2020-09-30 | $238.10M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $235.43M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $233.21M 10-Q · filed 2020-04-30 | |
| 2019-12-31 | $239.72M 10-K · filed 2023-02-16 | |
| 2019-09-30 | $212.17M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $215.16M 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $214.52M 10-Q · filed 2019-05-01 | |
| 2018-12-31 | $214.49M 10-K · filed 2022-02-16 | |
| 2018-09-30 | $216.05M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $195.97M 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $201.02M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $199.87M 10-K · filed 2021-02-12 | |
| 2017-09-30 | $199.52M 10-Q · filed 2017-10-31 | |
| 2017-06-30 | $196.67M 10-Q · filed 2017-08-01 | |
| 2017-03-31 | $180.60M 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $178.23M 10-K · filed 2020-02-14 | |
| 2016-09-30 | $180.95M 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $180.66M 10-Q · filed 2016-08-02 | |
| 2016-03-31 | $181.94M 10-Q · filed 2016-04-29 | |
| 2015-12-31 | $178.93M 10-K · filed 2019-02-15 | |
| 2015-09-30 | $180.39M 10-Q · filed 2015-10-28 | |
| 2015-06-30 | $179.71M 10-Q · filed 2015-07-30 | |
| 2015-03-31 | $176.93M 10-Q · filed 2015-04-28 | |
| 2014-12-31 | $184.45M 10-K · filed 2018-02-16 | |
| 2014-09-30 | $176.54M 10-Q · filed 2014-10-24 | |
| 2014-06-30 | $181.62M 10-Q · filed 2014-07-25 | |
| 2014-03-31 | $180.47M 10-Q · filed 2014-04-25 | |
| 2013-12-31 | $180.52M 10-K · filed 2017-02-17 | |
| 2013-09-30 | $180.99M 10-Q · filed 2013-10-22 | |
| 2013-06-30 | $171.40M 10-Q · filed 2013-07-23 | |
| 2013-03-31 | $172.46M 10-Q · filed 2013-04-23 | |
| 2012-12-31 | $174.99M 10-K · filed 2016-02-17 | |
| 2012-09-30 | $174.61M 10-Q · filed 2012-10-19 | |
| 2012-06-30 | $170.93M 10-Q · filed 2012-07-20 | |
| 2012-03-31 | $175.10M 10-Q · filed 2012-04-20 | |
| 2011-12-31 | $172.61M 10-K · filed 2015-02-17 | |
| 2011-09-30 | $150.02M 10-Q · filed 2011-10-21 | |
| 2011-06-30 | $154.19M 10-Q · filed 2011-07-22 | |
| 2011-03-31 | $152.50M 10-Q · filed 2011-04-21 | |
| 2010-12-31 | $149.11M 10-K · filed 2014-02-18 | |
| 2010-09-30 | $148.60M 10-Q · filed 2010-10-22 | |
| 2010-06-30 | $143.25M 10-Q · filed 2010-07-23 | |
| 2009-12-31 | $148.71M 10-K · filed 2013-02-19 | |
| 2008-12-31 | $138.77M 10-K · filed 2012-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |